About alogliptin
DPP-4 inhibitor antidiabetic
Used for
- Improves blood sugar control in adults with type 2 diabetes, alongside diet and exercise.
- May be combined with other diabetes medicines, including pioglitazone.
Usual adult dose
Alogliptin is usually taken as 25 mg once daily; dose may be reduced for kidney problems. Combination dosing depends on the prescribed product.
Common side effects
- Cold-like symptoms, headache, or upper respiratory infection.
- Low blood sugar, especially when combined with insulin or sulfonylureas.
- Stomach discomfort or rash.
- Rarely, severe joint pain or pancreatitis.
Important warnings
- Not for type 1 diabetes or diabetic ketoacidosis.
- Seek urgent care for severe, persistent abdominal pain that may indicate pancreatitis.
- Report signs of heart failure, such as breathlessness or leg swelling.
- Kidney function affects dosing; allergic reactions and serious skin reactions can occur.
Pregnancy
Use only if clearly needed; pregnancy data are limited. Diabetes treatment during pregnancy requires clinician supervision.
Breastfeeding
It is unknown whether alogliptin passes into breast milk; discuss use with a healthcare professional.
Interactions
- Insulin or sulfonylureas can increase low blood sugar risk; doses may need adjustment.
- Other glucose-lowering medicines can affect blood sugar control.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.